---
title: Cytel vs OCT Clinical
slug_a: cytel
slug_b: oct-clinicaltrials
site: cro
review_signal_gate: closed
canonical_path: /compare/cytel/oct-clinicaltrials
---

# Cytel vs OCT Clinical

Side-by-side profile data from each company listing on this directory.

## Cytel

- Profile: [/companies/cytel](/companies/cytel)

Cytel — Cytel provides data science and advanced analytics solutions across the drug development lifecycle, from discovery through commercialization, including clinical trial design, adaptive trial strategies, real-world evidence, and regulatory support.

Services: 12. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Computational & In-Silico Drug Discovery
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- Translational Research

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Discovery
- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Functional Service Provider (FSP)

## OCT Clinical

- Profile: [/companies/oct-clinicaltrials](/companies/oct-clinicaltrials)

OCT Clinical — OCT Clinical runs Phase I–IV and BE trials across Central and Eastern Europe, including first-in-human and post-authorization studies. Its network of principal investigators covers more than 1,600 medical sites.

Services: 10. Modalities: 0. Indications: 5. Locations: 20. Certifications: 0. The strongest documented coverage currently appears in locations (20).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Oncology
- Neurology
- Psychiatry
- Infectious Disease
- Gastroenterology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)